Skip to main content
Equibles
BMRA logo

BMRA · Biomerica Inc · Investor Relations

Track BMRA — free

Use BMRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BMRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.68 -0.03 (-1.75%)
Rebalance outlook locked
Going-concern doubt — flagged Oct 15, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about our ability to continue as a going concern within twelve months following the issuance date of these financial statements. Our future viability depends on the successful execution of our strategic plans, securing additional near-term financing, and achieving profitable operations.”
View the 10-Q filed Oct 15, 2026
Market Cap
$7.86M
Shares
4.60M
Volume · Oct 22 1986 Avg daily vol (3M) 70.76K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-10-16 Biomerica Reports First Quarter Fiscal 2027 Financial Results
2026-09-01 Biomerica Reports Fiscal 2026 Year-End Financial Results
2026-08-27 Biomerica Announces $2.23 Million Financing
2026-05-28 Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
2026-04-29 Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
2026-04-16 Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
2026-04-14 Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
2026-04-13 Biomerica Reports Third Quarter Fiscal 2026 Financial Results
2026-03-18 Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
2026-03-05 Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
2026-02-26 Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
2026-02-18 Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
2026-01-14 Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Past events

Date Event Type
2026-07-26 ADLM 2026 Annual Meeting Shareholder meeting
2026-05-02 Digestive Disease Week® (DDW) 2026 Event
2024-05-19 DDW® 2024 Event

Source: https://investors.biomerica.com/overview/default.aspx

Key facts CIK 73290 CUSIP 09061H406 Visit website Investor relations